✦ LIBER ✦

First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma

✍ Scribed by Patrizia Tosi; Elena Zamagni; Claudia Cellini; Raffaele Parente; Delia Cangini; Paola Tacchetti; Giulia Perrone; Michela Ceccolini; Paola Boni; Sante Tura; Michele Baccarani; Michele Cavo

Book ID: 114676140
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 136 KB
Volume: 76
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.0902-4441.2005.t01-1-ejh2520.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line thalidomide–dexamethasone the

First-line thalidomide–dexamethasone therapy in preparation for auto-SCT in young patients (<61 years) with symptomatic multiple myeloma

✍ Abdelkefi, A; Torjman, L; Ben Romdhane, N; Ladeb, S; Omri, H El; Ben Othman, T; 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 50 KB

First-line thalidomide–dexamethasone the

First-line thalidomide–dexamethasone therapy in preparation for autologous stem cell transplantation in young patients (<61 years) with symptomatic multiple myeloma

✍ Abdelkefi, A; Torjman, L; Ben Romdhane, N; Ladeb, S; El Omri, H; Ben Othman, T; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 139 KB

The Bisphosphonate Zoledronic Acid Induc

The Bisphosphonate Zoledronic Acid Induces Cytotoxicity in Human Myeloma Cell Lines with Enhancing Effects of Dexamethasone and Thalidomide

✍ A. Ugur Ural; M. Ilker Yilmaz; Ferit Avcu; Aysel Pekel; Murat Zerman; Oral Nevru 📂 Article 📅 2003 🏛 Carden Jennings Publishing 🌐 English ⚖ 318 KB

Low-dose thalidomide plus low-dose dexam

Low-dose thalidomide plus low-dose dexamethasone therapy in patients with refractory multiple myeloma

✍ Hirokazu Murakami; Hiroshi Handa; Masahiro Abe; Sinsuke Iida; Akihiro Ishii; Ta 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

Thalidomide versus bortezomib based regi

Thalidomide versus bortezomib based regimens as first-line therapy for patients with multiple myeloma: A systematic review

✍ Ambuj Kumar; Iztok Hozo; Keath Wheatley; Benjamin Djulbegovic 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

Bortezomib, thalidomide, dexamethasone i

Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP)

✍ Hyeon-Seok Eom; Yeo-Kyeoung Kim; Joo-Seop Chung; Kihyun Kim; Hyo Jung Kim; Ho Yo 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 153 KB